Skip to main content

Table 3 Diagnosis accuracy of QuantiFERON-TB Gold In-Tube and T-SPOT.TB

From: Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis

Test/Group

Sensitivity

(95% CI)

Specificity

(95% CI)

Positive LR

(95% CI)

Negative LR

(95% CI)

DOR

(95% CI)

1. QFT-GIT

     

 1.1 Overall

0.77

(0.71–0.82)

0.70

(0.58–0.80)

2.61

(1.80–3.80)

0.33

(0.25–0.42)

8.03

(4.51–14.31)

 1.2 Risk of bias

     

  Low risk of bias

0.77

(0.69–0.83)

0.69

(0.56–0.79)

2.46

(1.83–3.31)

0.34

(0.28–0.41)

7.28

(5.39–9.85)

  At risk of bias

0.76

(0.68–0.82)

0.71

(0.50–0.86)

2.64

(1.36–5.12)

0.34

(0.22–0.51)

7.85

(2.81–21.90)

 1.3 TB burden

     

 High TB burden country

0.74

(0.66–0.81)

0.57

(0.42–0.71)

1.74

(1.30–2.33)

0.45

(0.36–56)

3.84

(2.45–6.02)

 Low TB burden country

0.80

(0.71–0.85)

0.77

(0.62–0.87)

3.39

(2.02–5.68)

0.27

(0.19–0.39)

12.38

(5.92–25.89)

 1.4 Excluding studies of patients with HIV and immunocompromised status

0.79

(0.73–0.84)

0.72

(0.59–0.83)

2.86

(1.86–4.40)

0.29

(0.22–0.38)

8.85

(5.36–18.11)

2.T-SPOT.TB

0.74

(0.71–0.78)

0.71

(0.49–0.86)

2.53

(1.26–5.07)

0.36

(0.24–0.55)

6.96

(2.31–20.98)

  1. CI, confidence interval; DOR, diagnostic odds ratio; HIV, human immunodeficiency virus; LR likelihood ratio; QFT-GIT, QuantiFERON-TB Gold In-Tube; TB, tuberculosis